Lv4
440 积分 2024-09-07 加入
Imaging of Cardiac and Nonaortic Thoracic Vascular Trauma
27天前
已完结
The “A-B-C” classification reveals outcome trajectories in patients with hepatocellular carcinoma under atezolizumab/bevacizumab
3个月前
已完结
Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients
4个月前
已完结
Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA
4个月前
已完结
皖公网安备34019202002308
